InvestorsHub Logo
Followers 0
Posts 19
Boards Moderated 0
Alias Born 06/12/2017

Re: None

Friday, 09/21/2018 11:07:28 AM

Friday, September 21, 2018 11:07:28 AM

Post# of 1463
Oncocyte has posted a recent corporate presentation.
http://investors.oncocyte.com/~/media/Files/O/Oncocyte-IR/events-and-presentations/oncocyte-corporate-presentation-18-9-2018.pdf

While we have seen most of this information before, it does seem we're getting closer. This presentation says that all of the data should be in Q4 and then final commercialisation in H2-2019. It seems to me that they are showing their process works in this presentation. The testing now is to confirm officially that it works. If that is the case then we'll know in the next few months.

Yes, we have been here before a year ago when they found a problem with the consumables in the testing.

I'm hoping for
Renevia approval from Europe.
good feedback from the CA doctor (Gordon H. Sasaki,) who is trialling Renevia. He has said that he will be able to see the benefits of Premvia within 3 months.
good results from the opRegen trials with candidates whose eyesight is not too far gone.

The next few months could be interesting.
I'm in England and it's Miller time.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTX News